Chromium Yeast
Chromium grown into Saccharomyces cerevisiae yeast — a 'whole-food' chromium delivery form that's better absorbed than inorganic chromium chloride. Reasonable choice if you've decided to supplement chromium and prefer a food-bound form; not clearly better than chromium picolinate or chromium nicotinate / polynicotinate for clinical outcomes.
Quick decision guide
May help most
Adults with documented insulin resistance or impaired glucose tolerance who want a food-matrix chromium form, under clinician oversight.
Common dosing range
Supplements typically supply 100–400 mcg elemental chromium per serving; clinical trials have used 200–1000 mcg/day.
When to expect effects
Weeks to months for glycaemic biomarkers — 8 months in the Cefalu trial.
Watch out for
Saccharomyces yeast can rarely trigger allergic or immune reactions; avoid if you have a known yeast allergy or Crohn's disease (yeast antibodies are implicated).
Evidence snapshot
What is it
Chromium yeast is brewer's or nutritional yeast grown in a chromium-rich medium, naturally incorporating chromium into yeast proteins and other compounds. It is marketed as a 'whole-food' source of chromium with high bioavailability.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
Correcting marginal chromium intake Good Evidence | Significant rise in plasma chromium vs inorganic salts at matched elemental dose | Adults with low dietary chromium (highly refined / low-whole-grain diets, parenteral nutrition recipients) | Weeks for plasma chromium |
Insulin sensitivity in impaired glucose tolerance Limited Evidence | Improved clamp-measured insulin sensitivity in responders; no overall group difference at 8 months | Adults with impaired glucose tolerance and low baseline insulin sensitivity | Months (8-month trial duration) |
Type 2 diabetes glycaemic control Limited Evidence | Yeast form: modest fasting-glucose reduction; picolinate at 1000 mcg: ~1% HbA1c drop in the Anderson Chinese trial, not robustly replicated elsewhere | Adults with type 2 diabetes and possibly low chromium status | Weeks to months |
Body composition / weight loss Mixed Evidence | Small (<1 kg) and inconsistent across forms and trials | Not clearly identified | Not reliably established |
Correcting marginal chromium intake
- Effect
- Significant rise in plasma chromium vs inorganic salts at matched elemental dose
- Best fit
- Adults with low dietary chromium (highly refined / low-whole-grain diets, parenteral nutrition recipients)
- Time
- Weeks for plasma chromium
Insulin sensitivity in impaired glucose tolerance
- Effect
- Improved clamp-measured insulin sensitivity in responders; no overall group difference at 8 months
- Best fit
- Adults with impaired glucose tolerance and low baseline insulin sensitivity
- Time
- Months (8-month trial duration)
Type 2 diabetes glycaemic control
- Effect
- Yeast form: modest fasting-glucose reduction; picolinate at 1000 mcg: ~1% HbA1c drop in the Anderson Chinese trial, not robustly replicated elsewhere
- Best fit
- Adults with type 2 diabetes and possibly low chromium status
- Time
- Weeks to months
Body composition / weight loss
- Effect
- Small (<1 kg) and inconsistent across forms and trials
- Best fit
- Not clearly identified
- Time
- Not reliably established
Evidence for 4 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
Correcting marginal chromium intake
Corrects deficiencyChromium-enriched yeast reliably raises plasma chromium more than inorganic chromium chloride at the same elemental dose. For adults with low chromium intake from food, yeast-bound chromium is a sensible food-matrix way to reach the 25–35 mcg/day adequate intake.
Bottom line: Good food-bound option if you've decided to supplement chromium at all.
Insulin sensitivity in impaired glucose tolerance
Disease adjunctThe Cefalu et al. 2010 randomised double-blind trial gave 1000 mcg/day chromium as chromium-enriched yeast to adults with impaired glucose tolerance over 8 months. Insulin sensitivity (gold-standard hyperinsulinemic-euglycemic clamp) improved in a 'responder' subgroup characterised by lower baseline insulin sensitivity, but the overall group difference vs placebo was not significant. Plasma chromium rose meaningfully on the yeast form, confirming absorption.
Bottom line: Helpful for some prediabetic adults; not a one-size-fits-all glucose drug.
Evidence is mixed
Responder analyses are post-hoc and don't replace the primary endpoint, which was negative. Chromium trials show consistent baseline-dependent variability — the people who benefit most are the ones who started with the worst glucose handling.
Type 2 diabetes glycaemic control
Disease adjunctBahijri et al. 2000 crossover RCT in 78 adults with type 2 diabetes found chromium-enriched yeast (200 mcg) lowered fasting glucose more than chromium chloride at the same dose, supporting both better bioavailability and a glycaemic effect. The most widely cited diabetes data — Anderson 1997 in China — used chromium picolinate at 1000 mcg/day and reported HbA1c, glucose, and insulin improvements. Western replications have been inconsistent. The form-specific yeast data are smaller than the picolinate literature.
Bottom line: Worth a tracked 12-week trial with a clinician if HbA1c is stubborn despite standard treatment; don't expect it to replace metformin.
Body composition / weight loss
Supplement benefitChromium supplementation (any form) shows small, inconsistent effects on body weight and fat mass in meta-analyses. Yeast-form trials specifically for weight loss are limited. Marketing claims of 'fat burning' or significant body-recomposition are not supported by trial evidence.
Bottom line: Don't supplement chromium for weight loss.
How it works
How to take it
What to track
Bottom line: Start at 200 mcg elemental chromium with the largest meal. Reassess at 12 weeks with objective glycaemic markers, not subjective 'feel'.
4 commercial forms
Compare the main delivery options and what they’re best suited for.
Chromium-enriched Saccharomyces yeast
Food-matrix formSaccharomyces cerevisiae grown in chromium-rich medium so the mineral is incorporated into yeast biomass. The form used in the Cefalu impaired-glucose-tolerance RCT. Better plasma absorption than inorganic chromium chloride.
Higher than inorganic salts at matched elemental dose.
Chromium picolinate
Most studied formChromium bound to picolinic acid. The form used in the Anderson 1997 Chinese type 2 diabetes RCT and the most widely studied chromium supplement overall. Generic chromium content lives on the chromium-picolinate page.
Highly bioavailable; some kidney/liver case reports at very high chronic doses.
Chromium polynicotinate / nicotinate
Niacin-boundChromium bound to nicotinic acid (niacin). Bioavailable; some marketers claim it avoids the safety issues attributed to picolinic acid, but head-to-head safety data are limited.
Comparable to picolinate; differs in carrier molecule.
Chromium chloride (CrCl3)
Cheapest, least bioavailableInorganic chromium salt — used as the comparator in many bioavailability studies. Poorly absorbed (<2%) compared to organic chromium forms. Sometimes found in cheap multivitamins.
Low absorption (~0.5–2% of elemental dose).
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Allergic and immune reactions to Saccharomyces yeast are rare but possible — anti-Saccharomyces antibodies (ASCA) are a marker associated with Crohn's disease.
Case reports of kidney and liver injury at very high chronic chromium doses (mostly chromium picolinate at 600–2,400 mcg/day for months). Yeast form has no similar case reports, but caution at doses above standard supplement levels is sensible.
Hypoglycaemia risk when combined with insulin or sulfonylureas in adults already at glycaemic target — drug-dose adjustment may be needed.
Who should avoid it
- People with a known yeast allergy or Saccharomyces hypersensitivity.
- People with Crohn's disease — anti-Saccharomyces antibodies are common, and yeast challenges may be poorly tolerated.
- Severely immunocompromised individuals — even probiotic Saccharomyces strains have occasionally caused fungaemia in this population.
- People on insulin or oral hypoglycaemics without close glucose monitoring.
- People with significant kidney or liver impairment — discuss with a clinician before supplementing.
Pregnancy & breastfeeding
The chromium adequate intake during pregnancy is 30 mcg/day (29 mcg for adolescents) and 45 mcg/day during lactation; these are easily met from food. Chromium supplements specifically during pregnancy are not well studied — stay within prenatal-vitamin chromium levels unless your obstetrician recommends otherwise.
Bottom line: Generally well tolerated. The yeast-specific cautions are allergy and Crohn's; the chromium-wide caution is medication co-management.
Interactions
Chromium may improve insulin sensitivity in some users, increasing the risk of hypoglycaemia at unchanged drug doses.
Chromium can reduce levothyroxine absorption when taken together — separate doses by at least 4 hours.
Possible additive glucose-lowering effect — usually clinically welcome but warrants monitoring.
May reduce chromium absorption by altering gastric pH.
Theoretical increased chromium absorption / retention; clinical relevance unclear.
Beta-blockers can blunt the warning signs of hypoglycaemia — relevant if chromium contributes to glucose-lowering on diabetes therapy.
Food sources
| Food | Amount | %DV |
|---|---|---|
| Brewer's yeast, dry | 1 tbsp (~10–60 mcg, highly variable) | — |
| Mussels, cooked | 3 oz (~57 mcg) | 163% |
| Brazil nuts | 1 oz (~12 mcg) | 34% |
| Oysters, cooked | 3 oz (~7 mcg) | 20% |
| Broccoli, cooked | ½ cup (~11 mcg) | 31% |
| Grape juice | 1 cup (~8 mcg) | 23% |
| Whole-wheat English muffin | 1 muffin (~4 mcg) | 11% |
| Beef, ground | 3 oz (~2 mcg) | 6% |
| Turkey breast | 3 oz (~2 mcg) | 6% |
| Apple with peel | 1 medium (~1 mcg) | 3% |
Brewer's yeast, dry
- Amount
- 1 tbsp (~10–60 mcg, highly variable)
- %DV
- —
Mussels, cooked
- Amount
- 3 oz (~57 mcg)
- %DV
- 163%
Brazil nuts
- Amount
- 1 oz (~12 mcg)
- %DV
- 34%
Oysters, cooked
- Amount
- 3 oz (~7 mcg)
- %DV
- 20%
Broccoli, cooked
- Amount
- ½ cup (~11 mcg)
- %DV
- 31%
Grape juice
- Amount
- 1 cup (~8 mcg)
- %DV
- 23%
Whole-wheat English muffin
- Amount
- 1 muffin (~4 mcg)
- %DV
- 11%
Beef, ground
- Amount
- 3 oz (~2 mcg)
- %DV
- 6%
Turkey breast
- Amount
- 3 oz (~2 mcg)
- %DV
- 6%
Apple with peel
- Amount
- 1 medium (~1 mcg)
- %DV
- 3%
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Is chromium yeast better than other chromium forms?⌄
Some studies suggest modestly better absorption, but clinical advantages are not clearly established.
References by claim
Track Chromium Yeast with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.